Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease

I Bos, SJB Vos, SE Schindler, J Hassenstab… - Alzheimer's & …, 2019 - Elsevier
Introduction Vascular factors increase the risk of Alzheimer's disease (AD). We investigated
the associations between such factors, longitudinal AD cerebrospinal fluid biomarkers, and …

[HTML][HTML] Toxic tau: structural origins of tau aggregation in Alzheimer's disease

A Al Mamun, MS Uddin, B Mathew… - Neural Regeneration …, 2020 - journals.lww.com
Alzheimer's disease is characterized by the extracellular accumulation of the amyloid β in
the form of amyloid plaques and the intracellular deposition of the microtubule-associated …

[HTML][HTML] Caspase-cleaved tau co-localizes with early tangle markers in the human vascular dementia brain

RJ Day, MJ Mason, C Thomas, WW Poon, TT Rohn - PloS one, 2015 - journals.plos.org
Vascular dementia (VaD) is the second most common form of dementia in the United States
and is characterized as a cerebral vessel vascular disease that leads to ischemic episodes …

[HTML][HTML] The role of extracellular Tau in the spreading of neurofibrillary pathology

M Medina, J Avila - Frontiers in cellular neuroscience, 2014 - frontiersin.org
The microtubule-associated protein (MAP) tau plays a critical role in the pathogenesis of
Alzheimer's disease (AD) and several related disorders collectively known as tauopathies …

[HTML][HTML] Role of the lipid membrane and membrane proteins in tau pathology

E Bok, E Leem, BR Lee, JM Lee, CJ Yoo… - Frontiers in cell and …, 2021 - frontiersin.org
Abnormal accumulation of misfolded tau aggregates is a pathological hallmark of various
tauopathies including Alzheimer's disease (AD). Although tau is a cytosolic microtubule …

Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease

D Terwel, I Dewachter, F Van Leuven - Neuromolecular medicine, 2002 - Springer
The molecular causes and the genetic and environmental modifying factors of the sporadic
form of Alzheimer's disease (AD) remain elusive. Extrapolating from the known mutations …

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

VL Villemagne, V Doré, SC Burnham… - Nature Reviews …, 2018 - nature.com
Most neurodegenerative disorders are associated with aggregated protein deposits. In the
case of Alzheimer disease (AD), extracellular amyloid-β (Aβ) aggregates and intracellular …

Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's …

JA Wells, HE Holmes, JM O'callaghan… - Journal of Cerebral …, 2015 - journals.sagepub.com
Vascular abnormalities are a key feature of Alzheimer's disease (AD). Imaging of cerebral
vascular reactivity (CVR) is a powerful tool to investigate vascular health in clinical …

The tangled biology of tau

KC Wilhelmsen - Proceedings of the National Academy of …, 1999 - National Acad Sciences
With the aging of the population comes a heightened sense of urgency to do something
about Alzheimer's disease (AD), the most common dementia disorder. Treatment for AD is …

[HTML][HTML] Analysis of in vivo turnover of tau in a mouse model of tauopathy

K Yamada, TK Patel, K Hochgräfe, TE Mahan… - Molecular …, 2015 - Springer
Background Intracellular accumulation of tau as neurofibrillary tangles (NFTs) is the
hallmark of Alzheimer's disease (AD) as well as in other tauopathies. Tau is present not only …